SEC Form 4 · accession 0001140361-15-043718
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andre Walker
Officer — Senior VP,Research&Development
Period of report
Dec 2, 2015
Accepted (ET)
Dec 4, 2015 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 2, 2015 | M | 1,000 | $0.96 | A | 1,470 | D | |
| Common Stock | Dec 2, 2015 | S | 1,000 | $64.00 | D | 470 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.96 | Dec 2, 2015 | M | 1,000 | D | — | Dec 12, 2017 | Common Stock | 1,000 | 302 | D |
Explanation of responses
- F1The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2100% of the shares subject to the option are fully vested and exercisable.